0

ACROBiosystems: Custom GMP-grade protein services to drive cell and gene therapy

  • Friday, June 2, 2023 @ 12:00 am

To assist with the transition from preclinical to clinical research, premium-grade reagents are offered, as a ‘snapshot’ into the performance of GMP-grade reagents.

Cell and gene therapy (CGT) is a cutting-edge therapy that combats cancer by bolstering the immune system through stem cell infusions or modified immune cells. However, manufacturing cell therapies is no easy feat. Cell therapy products have a higher R&D and production requirement, alongside stricter regulatory requirements for performance, quality, consistency, and safety.

To support the commercialization of cell therapies, ACROBiosystems is now offering a global custom GMP-grade protein services. As part of their service platform for preclinical / clinical research, ACROBiosystems’ custom GMP-grade protein services is specifically designed for raw or ancillary materials used in CGT manufacturing.

Supporting ACROBiosystems’ custom GMP-grade protein services will be an expansive GMP-grade production facility, boasting over 180,000 sq. ft. dedicated to manufacturing GMP-grade products such as proteins, enzymes, and antibodies. This aligns with ACROBiosystems’ commitment to providing the high-quality reagents for their customers’ clinical research and commercial production requirements across the globe.

Keep browsing

You may also be interested in